Keyword Index

Browse for an article via relevant keywords across our entire electronic archive

Search results for: G
Results 131 - 140 of 306 shown below

  • genetic counselling

    S van Dijk, W Otten, M W Zoeteweij, D R M Timmermans, C J van Asperen, M H Breuning, R A E M Tollenaar and J Kievit

    Genetic counselling and the intention to undergo prophylactic mastectomy: effects of a breast cancer risk assessment

    doi:10.1038/sj.bjc.6600988

  • E A Lobb, P N Butow, A Barratt, B Meiser, C Gaff, M A Young, E Haan, G Suthers, M Gattas and K Tucker

    Communication and information-giving in high-risk breast cancer consultations: influence on patient outcomes

    doi:10.1038/sj.bjc.6601502

  • S Holloway, M Porteous, R Cetnarskyj, E Anderson, R Rush, A Fry, D Gorman, M Steel and H Campbell

    Patient satisfaction with two different models of cancer genetic services in south-east Scotland

    doi:10.1038/sj.bjc.6601562

  • A C Antoniou, P P D Pharoah, P Smith and D F Easton

    The BOADICEA model of genetic susceptibility to breast and ovarian cancer

    advance online publication, 2004-09-21 00:00:00.000;

    doi:10.1038/sj.bjc.6602175

  • N Torrance, J Mollison, S Wordsworth, J Gray, Z Miedzybrodzka, N Haites, A Grant, M Campbell, M S Watson, A Clarke and B Wilson

    Genetic nurse counsellors can be an acceptable and cost-effective alternative to clinical geneticists for breast cancer risk genetic counselling. Evidence from two parallel randomised controlled equivalence trials

    advance online publication, 2006-07-11 00:00:00.000;

    doi:10.1038/sj.bjc.6603248

  • C Apicella, S J Peacock, L Andrews, K Tucker, M B Daly and J L Hopper

    Measuring, and identifying predictors of, women's perceptions of three types of breast cancer risk: population risk, absolute risk and comparative risk

    advance online publication, 2009-02-10 00:00:00.000;

    doi:10.1038/sj.bjc.6604910

  • T M U Wagner, R Möslinger, G Langbauer, R Ahner, E Fleischmann, A Auterith, A Friedmann, T Helbich, C Zielinski, E Pittermann, M Seifert and P Oefner

    Attitude towards prophylactic surgery and effects of genetic counselling in families with BRCA mutations

    doi:10.1054/bjoc.1999.1086

  • A Cull, A Fry, R Rush and C M Steel

    Cancer risk perceptions and distress among women attending a familial ovarian cancer clinic

    doi:10.1054/bjoc.2000.1651

  • D Wonderling, P Hopwood, A Cull, F Douglas, M Watson, J Burn and K McPherson

    A descriptive study of UK cancer genetics services: an emerging clinical response to the new genetics

    doi:10.1054/bjoc.2001.1893

  • genetic damage

    P A Lazo

    The molecular genetics of cervical carcinoma

    doi:10.1038/sj.bjc.6690635

  • genetic epidemiology

    K Hemminki and Y Jiang

    Cancer risks among long-standing spouses

    doi:10.1038/sj.bjc.6600302

  • S E Bojesen, A Tybjærg-Hansen, C K Axelsson and B G Nordestgaard

    No association of breast cancer risk with integrin beta3 (ITGB3) Leu33Pro genotype

    advance online publication, 2005-06-21 00:00:00.000;

    doi:10.1038/sj.bjc.6602674

  • K Hemminki, P Vaittinen, C Dong and D Easton

    Sibling risks in cancer: clues to recessive or X-linked genes?

    doi:10.1054/bjoc.2000.1585

  • genetic instability

    S L Smith, N L Bowers, D C Betticher, O Gautschi, D Ratschiller, P R Hoban, R Booton, M F Santibáñez-Koref and J Heighway

    Overexpression of aurora B kinase (AURKB) in primary non-small cell lung carcinoma is frequent, generally driven from one allele, and correlates with the level of genetic instability

    doi:10.1038/sj.bjc.6602779

  • X Wu, B Kemp, C I Amos, S E Honn, W Zhang, G L Walsh and M R Spitz

    Associations among telomerase activity, p53 protein overexpression, and genetic instability in lung cancer

    doi:10.1038/sj.bjc.6690378

  • genetic marker

    E Kettunen, M Aavikko, P Nymark, S Ruosaari, H Wikman, E Vanhala, K Salmenkivi, R Pirinen, A Karjalainen, E Kuosma and S Anttila

    DNA copy number loss and allelic imbalance at 2p16 in lung cancer associated with asbestos exposure

    advance online publication, 2009-03-31 00:00:00.000;

    doi:10.1038/sj.bjc.6605012

  • J W Clark, L Snell, R P C Shiu, F W Orr, N Maitre, C P H Vary, D J Cole and P H Watson

    The potential role for prolactin-inducible protein (PIP) as a marker of human breast cancer micrometastasis

    doi:10.1038/sj.bjc.6690799

  • genetic markers

    S Temam, M Trassard, G Leroux, J Bosq, B Luboinski, G Lenoir, J Bénard and F Janot

    Cytology vs molecular analysis for the detection of head and neck squamous cell carcinoma in oesopharyngeal brush samples: a prospective study in 56 patients

    doi:10.1038/sj.bjc.6600953

  • genetic polymorphism

    M-T Wu, J-M Lee, D-C Wu, C-K Ho, Y-T Wang, Y-C Lee, H-K Hsu and E-L Kao

    Genetic polymorphisms of cytochrome P4501A1 and oesophageal squamous-cell carcinoma in Taiwan

    doi:10.1038/sj.bjc.6600499

  • S E Bojesen, A Tybjærg-Hansen, C K Axelsson and B G Nordestgaard

    No association of breast cancer risk with integrin beta3 (ITGB3) Leu33Pro genotype

    advance online publication, 2005-06-21 00:00:00.000;

    doi:10.1038/sj.bjc.6602674

  • M Sarbia, M Stahl, C von Weyhern, G Weirich and F Pühringer-Oppermann

    The prognostic significance of genetic polymorphisms (Methylenetetrahydrofolate Reductase C677T, Methionine Synthase A2756G, Thymidilate Synthase tandem repeat polymorphism) in multimodally treated oesophageal squamous cell carcinoma

    advance online publication, 2005-12-06 00:00:00.000;

    doi:10.1038/sj.bjc.6602900

  • C-S Huang, C-Y Shen, K-J Chang, S-M Hsu and H-D Chern

    Cytochrome P4501A1 polymorphism as a susceptibility factor for breast cancer in postmenopausal Chinese women in Taiwan

    doi:10.1038/sj.bjc.6690608

  • P Lin, S-L Wang, H-J Wang, K-W Chen, H-S Lee, K-J Tsai, C-Y Chen and H Lee

    Association of CYP1A1 and microsomal epoxide hydrolase polymorphisms with lung squamous cell carcinoma

    doi:10.1054/bjoc.1999.1011

  • J Green, E Banks, A Berrington, S Darby, H Deo and R Newton

    N -acetyltransferase 2 and bladder cancer: an overview and consideration of the evidence for gene-environment interaction

    doi:10.1054/bjoc.2000.1265

  • M Bergman-Jungeström and S Wingren

    Catechol-O-Methyltransferase (COMT) gene polymorphism and breast cancer risk in young women

    doi:10.1054/bjoc.2001.2009

  • genetic polymorphism(s)

    S P Balasubramanian, N J Brown and M W R Reed

    Role of genetic polymorphisms in tumour angiogenesis

    doi:10.1038/sj.bjc.6600625

  • genetic polymorphisms

    M D Barber, J J Powell, S F Lynch, K C H Fearon and J A Ross

    A polymorphism of the interleukin-1 beta gene influences survival in pancreatic cancer

    doi:10.1054/bjoc.2000.1479

  • genetic predisposition

    A Baeyens, H Thierens, K Claes, B Poppe, L Messiaen, L De Ridder and A Vral

    Chromosomal radiosensitivity in breast cancer patients with a known or putative genetic predisposition

    doi:10.1038/sj.bjc.6600628

  • K De Ruyck, V de Gelder, M Van Eijkeren, T Boterberg, W De Neve, A Vral and H Thierens

    Chromosomal radiosensitivity in head and neck cancer patients: evidence for genetic predisposition?

    advance online publication, 2008-04-15 00:00:00.000;

    doi:10.1038/sj.bjc.6604345

  • R Papworth, N Slevin, S A Roberts and D Scott

    Sensitivity to radiation-induced chromosome damage may be a marker of genetic predisposition in young head and neck cancer patients

    doi:10.1054/bjoc.2000.1692